Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Alpha Cognition Inc V.ACOG

Alternate Symbol(s):  V.ACOG.W | ACOGF

Alpha Cognition Inc is a clinical-stage biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases such as Alzheimer's Disease and Amyotrophic Lateral Sclerosis. ALPHA-1062 is a patented new chemical entity that has demonstrated safety and improved tolerability in human clinical trials. It is being developed as a new acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type, with minimal gastrointestinal side effects and novel routes of administration.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

$ACOG.v announces new CFO and additions to the board

$ACOG.v recently announced the appointment of Don Kalkofen as Chief Financial Officer (CFO) and Michael McFadden, $ACOG ‘s CEO, to the board of directors https://ca.finance.yahoo.com/news/alpha...read more

$ACOG gets positive preclinical results for ALPHA-0602 drug

For those interested in the biopharma space, Alpha Cognition Inc. ($ACOG.v $ACOGF) is a company working on creating medication to help those with neurodegenerative disorders. It recently announced...read more

RE:$ACOG appoints new CFO

Some solid gains on the chart for $ACOG.v the past few days. Shares are up a solid 13% and holding!  rate and reply

$ACOG appoints new CFO

Last week, $ACOG announced they have appointed Don Kalkofen as CFO. Mr. Kalkofen has plenty of experience in the biotechnology industry and has been successful in the past serving as CFO of...read more

$ACOG.v Updates

As Alpha Cognition (TSXV: ACOG) enters its next phase of growth, the company has appointed Don Kalkofen as CFO. Don has considerable experience in corporate finance, as well as a strong track record...read more

You can check out $ACOG.v $ACOGF ’s pre-clinical data from A

You can check out $ACOG.v $ACOGF ’s pre-clinical data from ALPHA-1062 here    https://twitter.com/alpha_cognition/status/1514292342857121796   The data is promising, FDA...read more

$ACOG.v Appoints New CFO

As Alpha Cognition (TSXV: ACOG) enters its next phase of growth, the company has appointed Don Kalkofen as CFO. Don has considerable experience in corporate finance, as well as a strong track record...read more

$ACOG.v ‘s ALPHA-0602 shows potential for treating ALS

in pre-clinical studies, $ACOG.v ‘s ALPHA-0602 (Progranulin) gene therapy program has shown positive results in treating Amyotrophic Lateral Sclerosis (ALS). As announced by $ACOG last month published...read more

Recent News

If you missed it $ACOG.v $ACOGF recently announced positive preclinical data from their ALPHA-0602 ALS gene therapy program. The results further support the development of ALPHA-0602 for the...read more

News

$ACOG had some solid news last week; they announced positive preclinical data from their ALPHA-0602 ALS gene therapy program. These data backs up the robust preclinical evidence supporting Alpha...read more

$ACOG.v $ACOGF welcomes Chase Coburn as director, HoQ

$ACOG.v $ACOGF welcomes Chase Coburn as director, HoQ    https://twitter.com/alpha_cognition/status/1511376912115027971   With 16 years in the business Chase is an excellent...read more

$ACOG.v Reports Pre-Clinical Data For ALPHA-0602

Further positive data is coming from Alpha Cognition (TSXV: ACOG) with the announcement that in a recent clinical study, its ALPHA-0602 therapy has yielded positive evidence for its use in the...read more

$ACOG.v presentation at Life Sciences Investor Forum

have you watched $ACOG.v ‘s presentation at the Life Sciences Investor Forum yet? They’re now available for on-demand online viewing, I recommend you check them out. great source of info on the...read more

$ACOG - Life Sci Conferences Bump

$ACOG SP Bump after the Life Sciences Conference Raymond James Capital has given Alpha Cognition an “Outperform” rating with a new target price of 3.50. Positive PR from the conference has given...read more

$ACOG.v $ACOGF making great progress on their ALPHA-1062

$ACOG.v $ACOGF making great progress on their ALPHA-1062    https://twitter.com/Canadasmallcap/status/1504600424023699473   As we head closer to FDA approval this is the...read more

ACOG

$ACOGF $ACOG   $ACOG.V closed green @ $1.08 ,mc $66.42M    watching closely at these levels  before they meet with the FDA to discuss clinical development in the coming...read more

$ACOG.v | financial tips for caregivers

great article shared by $ACOG.v on financial tips for caregivers compiled by AgingCare https://www.agingcare.com/articles/tax-steps-for-new-caregivers-170589.htm the article serves as a guide...read more

Article on $ACOG.v

Came across this article on $ACOG.v $ACOGF and their recent results from their Alpha-1062 study. Touches on  - Success of the study - The neurogenic potential of Alpha-1062 - Plans to...read more

$ACOG presentation @LifeScienceInvestor forum now available

The Life Sciences Investor Forum which took place on March 10th has now made all the presentations from the conference including a. presentation by $ACOG.v available online for on-demand viewing. You...read more

$ACOG.v DD

Shares of Alpha Cognition (TSXV: ACOG) saw an increase in positive volume last week equal to levels the stock saw right before it rose 19.32% earlier this month.  The company’s stock recently...read more